持田製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2014/12/05 | 6,580 | 6,620 | 6,540 | 6,600 | -20 | -0.3% | 26,100 |
2014/12/04 | 6,660 | 6,700 | 6,600 | 6,620 | +20 | +0.3% | 29,700 |
2014/12/03 | 6,660 | 6,670 | 6,600 | 6,600 | -30 | -0.5% | 30,100 |
2014/12/02 | 6,540 | 6,640 | 6,540 | 6,630 | +90 | +1.4% | 22,700 |
2014/12/01 | 6,540 | 6,640 | 6,530 | 6,540 | +30 | +0.5% | 29,500 |
2014/11/28 | 6,540 | 6,600 | 6,490 | 6,510 | +10 | +0.2% | 41,400 |
2014/11/27 | 6,570 | 6,590 | 6,500 | 6,500 | -70 | -1.1% | 37,100 |
2014/11/26 | 6,660 | 6,670 | 6,560 | 6,570 | -100 | -1.5% | 58,800 |
2014/11/25 | 6,790 | 6,790 | 6,670 | 6,670 | -50 | -0.7% | 37,100 |
2014/11/21 | 6,770 | 6,780 | 6,670 | 6,720 | -50 | -0.7% | 36,000 |
2014/11/20 | 6,840 | 6,840 | 6,760 | 6,770 | -40 | -0.6% | 25,200 |
2014/11/19 | 6,780 | 6,940 | 6,780 | 6,810 | +30 | +0.4% | 43,300 |
2014/11/18 | 6,700 | 6,810 | 6,700 | 6,780 | +130 | +2% | 28,600 |
2014/11/17 | 6,750 | 6,820 | 6,620 | 6,650 | -170 | -2.5% | 30,900 |
2014/11/14 | 6,840 | 6,900 | 6,770 | 6,820 | +30 | +0.4% | 45,000 |
2014/11/13 | 6,750 | 6,850 | 6,670 | 6,790 | +40 | +0.6% | 50,900 |
2014/11/12 | 6,710 | 6,840 | 6,710 | 6,750 | +40 | +0.6% | 59,600 |
2014/11/11 | 6,730 | 6,780 | 6,660 | 6,710 | -20 | -0.3% | 66,400 |
2014/11/10 | 6,780 | 6,780 | 6,670 | 6,730 | -70 | -1% | 38,400 |
2014/11/07 | 6,700 | 6,850 | 6,700 | 6,800 | +50 | +0.7% | 39,100 |
2014/11/06 | 6,880 | 6,920 | 6,710 | 6,750 | -130 | -1.9% | 41,300 |
2014/11/05 | 6,850 | 6,960 | 6,800 | 6,880 | +30 | +0.4% | 47,600 |
2014/11/04 | 6,880 | 6,960 | 6,720 | 6,850 | +20 | +0.3% | 73,500 |
2014/10/31 | 6,490 | 6,940 | 6,490 | 6,830 | +350 | +5.4% | 54,600 |
2014/10/30 | 6,490 | 6,620 | 6,480 | 6,480 | -10 | -0.2% | 55,000 |
2014/10/29 | 6,430 | 6,550 | 6,390 | 6,490 | +130 | +2% | 38,300 |
2014/10/28 | 6,300 | 6,420 | 6,300 | 6,360 | +20 | +0.3% | 23,200 |
2014/10/27 | 6,400 | 6,400 | 6,310 | 6,340 | +10 | +0.2% | 24,400 |
2014/10/24 | 6,390 | 6,390 | 6,290 | 6,330 | -30 | -0.5% | 33,100 |
2014/10/23 | 6,530 | 6,550 | 6,330 | 6,360 | -230 | -3.5% | 46,600 |
2014/10/22 | 6,410 | 6,620 | 6,410 | 6,590 | +270 | +4.3% | 52,000 |
2014/10/21 | 6,400 | 6,470 | 6,280 | 6,320 | -100 | -1.6% | 38,900 |
2014/10/20 | 6,320 | 6,440 | 6,280 | 6,420 | +320 | +5.2% | 40,100 |
2014/10/17 | 6,000 | 6,250 | 5,970 | 6,100 | -200 | -3.2% | 82,000 |
2014/10/16 | 6,310 | 6,370 | 6,210 | 6,300 | -110 | -1.7% | 63,300 |
2014/10/15 | 6,720 | 6,780 | 6,280 | 6,410 | -510 | -7.4% | 99,400 |
2014/10/14 | 6,810 | 7,070 | 6,780 | 6,920 | ±0 | ±0% | 45,300 |
2014/10/10 | 6,990 | 7,040 | 6,870 | 6,920 | -170 | -2.4% | 39,000 |
2014/10/09 | 7,230 | 7,280 | 7,090 | 7,090 | -160 | -2.2% | 22,800 |
2014/10/08 | 7,230 | 7,340 | 7,120 | 7,250 | -90 | -1.2% | 26,300 |
2014/10/07 | 7,290 | 7,420 | 7,290 | 7,340 | +10 | +0.1% | 24,500 |
2014/10/06 | 7,310 | 7,350 | 7,310 | 7,330 | +80 | +1.1% | 9,100 |
2014/10/03 | 7,150 | 7,320 | 7,150 | 7,250 | +60 | +0.8% | 14,700 |
2014/10/02 | 7,360 | 7,370 | 7,190 | 7,190 | -240 | -3.2% | 19,900 |
2014/10/01 | 7,420 | 7,510 | 7,390 | 7,430 | +30 | +0.4% | 18,700 |
2014/09/30 | 7,510 | 7,510 | 7,380 | 7,400 | -100 | -1.3% | 17,700 |
2014/09/29 | 7,530 | 7,560 | 7,490 | 7,500 | -30 | -0.4% | 11,400 |
2014/09/26 | 7,560 | 7,580 | 7,490 | 7,530 | -50 | -0.7% | 19,600 |
2014/09/25 | 7,520 | 7,580 | 7,470 | 7,580 | +90 | +1.2% | 33,600 |
2014/09/24 | 7,420 | 7,500 | 7,420 | 7,490 | +10 | +0.1% | 19,400 |
2601~
2650
件表示中 / 3751件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
持田薬 | 308,500円 | +5.1% | -7.0% | 2.59% | 20.26倍 | 0.84倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
サンバイオ | 230,600円 | - | - | 0.00% | - | 106.81倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
ジーエヌアイ | 280,000円 | +21.7% | +999.9% | 0.00% | 11.73倍 | 3.88倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
ゼリア新薬 | 208,500円 | +3.1% | -6.5% | 2.30% | 9.68倍 | 1.02倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
JCRファーマ | 71,100円 | +14.3% | - | 2.81% | 28.91倍 | 1.85倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
市場注目の銘柄
チャート関連のコラム